Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001765581-19-000052
Filing Date
2019-08-07
Accepted
2019-08-07 18:37:06
Documents
2
Period of Report
2019-07-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1534
2 EDGAR SUPPORTING DOCUMENT poapatil.txt EX-24 3658
  Complete submission text file 0001765581-19-000052.txt   6695
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address JAZZ PHARMACEUTICALS 3170 PORTER DRIVE PALO ALTO CA 94304
Business Address
Patil Neena M (Reporting) CIK: 0001783908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33500 | Film No.: 191006938